Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy
Triple-negative breast cancer (TNBC) is a heterogeneous breast cancer subtype characterized by aggressive clinical behavior and poor prognosis. The immune landscape associated with TNBC often reveals high immunogenicity. Therefore, immunotherapy, which has demonstrated its efficacy in different canc...
Saved in:
| Main Authors: | Valérie Laurent-Matha, Pascal Roger, Séverine Guiu, Thierry Chardès, Emmanuelle Liaudet-Coopman, Pénélope Desroys du Roure, Timothée David, Aude Mallavialle |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-01-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/1/e009548.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases
by: Kexin Zhao, et al.
Published: (2024-12-01) -
Retrospective Analysis of Transcriptomic Differences between Triple-Negative Breast Cancer (TNBC) and non-TNBC
by: Çağlar Berkel
Published: (2024-05-01) -
The search for a TNBC vaccine: the guardian vaccine
by: Cory Fines, et al.
Published: (2025-12-01) -
PIBF1 expression and survival outcome in TNBC and Non-TNBC breast cancer patients with lymph node metastasis who undertaken chemotherapy
by: Eunju Shin, et al.
Published: (2025-08-01) -
Sustained release of cathepsin D/cathepsin K from injectable hydrogel microspheres in anti-photoaging
by: Wenyi Hou, et al.
Published: (2025-10-01)